Packaging and storage
Preserve in
Containers for Sterile Solidsas described under
Injections á1ñ,protected from light.
Labeling
Label Tetracycline Hydrochloride for Injection that contains an anesthetic agent to indicate that it is intended for intramuscular administration only.
Identification
The chromatogram of the Assay preparationobtained as directed in the Assayexhibits a major peak for tetracycline,the retention time of which corresponds to that exhibited in the chromatogram of the Standard preparationobtained as directed in the Assay.
pHá791ñ:
between 2.0and 3.0,in a solution containing 10mg per mL.
Loss on drying á731ñ
Dry about 100mg,accurately weighed,in a capillary-stoppered bottle in vacuum at a pressure not exceeding 5mm of mercury at 60

for 3hours:it loses not more than 5.0%of its weight.
Limit of 4-epianhydrotetracycline
Using the
Diluting solvent,
Chromatographic system,and
Procedureset forth in the
Assay,chromatograph a Standard solution prepared by dissolving an accurately weighed quantity of
USP4-Epianhydrotetracycline Hydrochloride RSin
Diluting solventto obtain a solution having a known concentration of about 15µg per mL.Using the chromatogram so obtained and the chromatogram of the
Assay preparationobtained as directed in the
Assay,calculate the percentage of 4-epianhydrotetracycline hydrochloride in the Tetracycline Hydrochloride for Injection taken by the formula:
(10CE/T)(rU/rS),
in which
CEis the concentration,in µg per mL,of
USP4-Epianhydrotetracycline Hydrochloride RSin the Standard solution;
Tis the quantity,in mg,of tetracycline hydrochloride in the portion of Tetracycline Hydrochloride for Injection taken to prepare the
Assay preparation,based on the labeled quantity;and
rUand
rSare the 4-epianhydrotetracycline peak responses obtained from the
Assay preparationand the Standard solution,respectively:not more than 3.0%is found.
Assay
Diluting solvent,Mobile phase,Standard preparation,Resolution solution,and Chromatographic system
Prepare as directed in the
Assayunder
Tetracycline Hydrochloride.
Assay preparation 1
(where it is represented as being in a single-dose container)Constitute Tetracycline Hydrochloride for Injection as directed in the labeling.Withdraw all of the withdrawable contents,using a suitable hypodermic needle and syringe,and dilute quantitatively and stepwise with Diluting solventto obtain a solution containing about 0.5mg of tetracycline hydrochloride per mL.
Assay preparation 2
(where the label states the quantity of tetracycline hydrochloride in a given volume of constituted solution)Constitute Tetracycline Hydrochloride for Injection as directed in the labeling.Dilute an accurately measured volume of the constituted solution quantitatively with Diluting solventto obtain a solution containing about 0.5mg of tetracycline hydrochloride per mL.
Procedure
Proceed as directed in the
Assayunder
Tetracycline Hydrochloride.Calculate the quantity,in mg,of C
22H
24N
2O
8.HCl withdrawn from the container,or in the portion of constituted solution taken by the formula:
(L/D)(CP/1000)(rU/rS),
in which
Lis the labeled quantity,in mg,of C
22H
24N
2O
8.HCl in the container,or in the volume of constituted solution taken;
Dis the concentration,in mg of tetracycline hydrochloride per mL,of
Assay preparation 1or
Assay preparation 2,based on the labeled quantity in the container or in the portion of constituted solution taken,respectively,and the extent of dilution;and the other terms are as defined therein.